Biocon
Biosimilars, Biologika und pharmazeutische Inhaltsstoffe.
Biocon stellt in seinem Betrieb in Bengaluru Biosimilars, Biologika und pharmazeutische Inhaltsstoffe her. Das Unternehmen beliefert Kunden aus den Bereichen Einzelhandel, Industrie, Gesundheitswesen, Gastronomie und Export in seinen aufgeführten Hauptmärkten.
- Type
- brand seeking distribution
- Location
- Bengaluru, India
- Founded
- 1978
- Website
- biocon.com
- Categories
- Medizin- & Gesundheitsbedarf
- Markets
- Indien, Vereinigte Staaten, Deutschland, Japan
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-05 Mail server of the company domain
- domain-registered (green), checked 2026-08-05 Domain registry record
- web-presence-since (green), checked 2026-08-02 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-08-05 OpenSanctions
- customer-reviews (amber), checked 2026-08-05 MouthShut
- debarment-clear (green), checked 2026-08-05 OpenSanctions
- export-registered (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- lei-active (green), checked 2026-08-30 GLEIF global LEI register (golden copy)
- certificate-page-on-site (amber), checked 2026-08-30 Company's own certification page
- registry-activity (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
Claimed certifications
- Good Manufacturing Practice
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)